TY - JOUR
T1 - Alternative ways of expressing forced expiratory volume in the first second and long-term mortality in elderly patients with asthma
AU - Pedone, Claudio
AU - Scarlata, Simone
AU - Zito, Anna
AU - Forastiere, Francesco
AU - Scichilone, Nicola
AU - Battaglia, Salvatore
AU - Bellia, Vincenzo
AU - Antonelli-Incalzi, Raffaele
PY - 2013/11
Y1 - 2013/11
N2 - Background Clinical and epidemiologic evidence on asthma in the elderly is scant. There is evidence that forced expiratory volume in the first second (FEV1), a commonly used indicator of overall pulmonary function, might not be an independent predictor of 5-year mortality in elderly patients with asthma. Objective To investigate the association between FEV1 expressed using 3 alternative methods and 5-, 10-, and 15-year mortality in a population of elderly patients with asthma. Methods Participants in the Salute Respiratoria nell' Anziano study were included. Asthma was diagnosed at baseline according to spirometric and clinical data. Vital status at 15 years was assessed using death registries. FEV1 was expressed as percentage of predicted, divided by height cubed, and as a multiple of the sex-specific first percentile. The association between FEV1 and mortality was evaluated using Cox proportional hazard models. Results Two hundred patients were studied (52% women, mean age 73.1 years, standard deviation 6.2 years). All FEV 1 measurements were associated with mortality at unadjusted analysis. After correction for potential confounders, no association was found between FEV1 and 5-year mortality. Only FEV1 as a multiple of the sex-specific first percentile was independently associated with 10-year (hazard ratio 0.35, 95% confidence interval 0.14-0.87) and 15-year (hazard ratio 0.38, 95% confidence interval 0.19-0.79) mortality. Conclusion Although extensively used, FEV1 expressed as percentage of predicted does not seem to be the best predictor of mortality in elderly patients with asthma. Although no spirometric index can predict 5-year mortality in this population, FEV 1 as a multiple of the sex-specific first percentile should be considered when longer-term prognostic stratification is needed.
AB - Background Clinical and epidemiologic evidence on asthma in the elderly is scant. There is evidence that forced expiratory volume in the first second (FEV1), a commonly used indicator of overall pulmonary function, might not be an independent predictor of 5-year mortality in elderly patients with asthma. Objective To investigate the association between FEV1 expressed using 3 alternative methods and 5-, 10-, and 15-year mortality in a population of elderly patients with asthma. Methods Participants in the Salute Respiratoria nell' Anziano study were included. Asthma was diagnosed at baseline according to spirometric and clinical data. Vital status at 15 years was assessed using death registries. FEV1 was expressed as percentage of predicted, divided by height cubed, and as a multiple of the sex-specific first percentile. The association between FEV1 and mortality was evaluated using Cox proportional hazard models. Results Two hundred patients were studied (52% women, mean age 73.1 years, standard deviation 6.2 years). All FEV 1 measurements were associated with mortality at unadjusted analysis. After correction for potential confounders, no association was found between FEV1 and 5-year mortality. Only FEV1 as a multiple of the sex-specific first percentile was independently associated with 10-year (hazard ratio 0.35, 95% confidence interval 0.14-0.87) and 15-year (hazard ratio 0.38, 95% confidence interval 0.19-0.79) mortality. Conclusion Although extensively used, FEV1 expressed as percentage of predicted does not seem to be the best predictor of mortality in elderly patients with asthma. Although no spirometric index can predict 5-year mortality in this population, FEV 1 as a multiple of the sex-specific first percentile should be considered when longer-term prognostic stratification is needed.
UR - http://www.scopus.com/inward/record.url?scp=84885952485&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885952485&partnerID=8YFLogxK
U2 - 10.1016/j.anai.2013.08.013
DO - 10.1016/j.anai.2013.08.013
M3 - Article
C2 - 24125145
AN - SCOPUS:84885952485
SN - 1081-1206
VL - 111
SP - 382
EP - 386
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 5
ER -